| Identification | Back Directory | [Name]
1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-7-fluoro-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- | [CAS]
2401894-00-4 | [Synonyms]
GLP-1R agonist 9 1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-7-fluoro-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- | [Molecular Formula]
C32H30ClF2N3O5 | [MOL File]
2401894-00-4.mol | [Molecular Weight]
610.05 |
| Hazard Information | Back Directory | [Uses]
GLP-1R agonist 9 (Compound 96) is a GLP-1R agonist with EC50 values of 1.1 nM and 11 nM against CHO GLP-1R Clone H6 and CHO GLP-1R Clone C6, respectively[1]. | [References]
[1] Gary E. Aspnes, et al. Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases. WO2020234726A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|